Cargando…
Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy
The appearance of chemoresistance in cancer is a major issue. The main barriers to conventional tumor chemotherapy are undesirable toxic effects and multidrug resistance. Cancer nanotherapeutics were developed to get around the drawbacks of conventional chemotherapy. Through clinical evaluation of t...
Autores principales: | Katopodi, Theodora, Petanidis, Savvas, Tsavlis, Drosos, Anestakis, Doxakis, Charalampidis, Charalampos, Chatziprodromidou, Ioanna, Eskitzis, Panagiotis, Zarogoulidis, Paul, Kosmidis, Christoforos, Matthaios, Dimitris, Porpodis, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634039/ https://www.ncbi.nlm.nih.gov/pubmed/36338748 http://dx.doi.org/10.3389/fonc.2022.1042125 |
Ejemplares similares
-
Tumor-Infiltrating Dendritic Cells: Decisive Roles in Cancer Immunosurveillance, Immunoediting, and Tumor T Cell Tolerance
por: Katopodi, Theodora, et al.
Publicado: (2022) -
Molecular and Immune Phenotypic Modifications during Metastatic Dissemination in Lung Carcinogenesis
por: Tsavlis, Drosos, et al.
Publicado: (2022) -
Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8(+)T Cell Immunity
por: Domvri, Kalliopi, et al.
Publicado: (2022) -
Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3/PTK2 immunosuppressive circuit
por: Katopodi, Theodora, et al.
Publicado: (2021) -
Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery
por: Katopodi, Theodora, et al.
Publicado: (2023)